Gene · 7013
Papers3,918
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,918
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A pro-metastatic tRNA fragment drives Nucleolin oligomerization and stabilization of its bound metabolic mRNAs. | Mol Cell | 2022 | 35654044 | PubTator, text mining | PubMed |
| Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance. | Front Oncol | 2022 | 35646668 | PubTator, text mining | PubMed |
| Context-Dependent Regulation of Gene Expression by Non-Canonical Small RNAs. | Noncoding RNA | 2022 | 35645336 | PubTator, text mining | PubMed |
| Targeting HMGB1: An available Therapeutic Strategy for Breast Cancer Therapy. | Int J Biol Sci | 2022 | 35637945 | PubTator, text mining | PubMed |
| Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties. | Pharmaceuticals (Basel) | 2022 | 35631373 | PubTator, text mining | PubMed |
| Influences of Long-Term Exercise and High-Fat Diet on Age-Related Telomere Shortening in Rats. | Cells | 2022 | 35626642 | PubTator, text mining | PubMed |
| High Expression of a tRNAPro Derivative Associates with Poor Survival and Independently Predicts Colorectal Cancer Recurrence. | Biomedicines | 2022 | 35625858 | PubTator, text mining | PubMed |
| G-Quadruplex-Binding Proteins: Promising Targets for Drug Design. | Biomolecules | 2022 | 35625576 | PubTator, text mining | PubMed |
| Relative Telomere Length Is Associated With Age-Related Macular Degeneration in Women. | Invest Ophthalmol Vis Sci | 2022 | 35612837 | PubTator, text mining | PubMed |
| Affinity Chromatography-Based Assays for the Screening of Potential Ligands Selective for G-Quadruplex Structures. | ChemistryOpen | 2022 | 35608081 | PubTator, text mining | PubMed |
| Multistage targeting and dual inhibiting strategies based on bioengineered tumor matrix microenvironment-mediated protein nanocages for enhancing cancer biotherapy. | Bioeng Transl Med | 2022 | 35600646 | PubTator, text mining | PubMed |
| Role of the TATA-box binding protein (TBP) and associated family members in transcription regulation. | Gene | 2022 | 35597524 | PubTator, text mining | PubMed |
| Serum tsRNA as a novel molecular diagnostic biomarker for lupus nephritis. | Clin Transl Med | 2022 | 35593207 | PubTator, text mining | PubMed |
| tRF-Val-CAC-016 modulates the transduction of CACNA1d-mediated MAPK signaling pathways to suppress the proliferation of gastric carcinoma. | Cell Commun Signal | 2022 | 35590368 | PubTator, text mining | PubMed |
| Ustilago maydis telomere protein Pot1 harbors an extra N-terminal OB fold and regulates homology-directed DNA repair factors in a dichotomous and context-dependent manner. | PLoS Genet | 2022 | 35587917 | PubTator, text mining | PubMed |
| The Root Hair Development of Pectin Polygalacturonase PGX2 Activation Tagging Line in Response to Phosphate Deficiency. | Front Plant Sci | 2022 | 35586221 | PubTator, text mining | PubMed |
| A novel 3'tRNA-derived fragment tRF-Val promotes proliferation and inhibits apoptosis by targeting EEF1A1 in gastric cancer. | Cell Death Dis | 2022 | 35585048 | PubTator, text mining | PubMed |
| Serum transfer RNA-derived fragment tRF-31-79MP9P9NH57SD acts as a novel diagnostic biomarker for non-small cell lung cancer. | J Clin Lab Anal | 2022 | 35576497 | PubTator, text mining | PubMed |
| Study of tRNA-Derived Fragment tRF-20-S998LO9D in Pan-Cancer. | Dis Markers | 2022 | 35571614 | PubTator, text mining | PubMed |
| Operable hepatitis B virus-related hepatocellular carcinoma: gut microbiota profile of patients at different ages. | Ann Transl Med | 2022 | 35571398 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7013/papers?page=39